BioAge Labs, Inc (BIOA) support and resistance · rev $9.0M
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
This page maps BioAge Labs, Inc (BIOA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
BIOA currently screens at market cap $697.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BIOA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BIOA quote page for the session range and the stock page for the full model.
Not investment advice.